Creative Biolabs is a global company that focuses on antibody development. With extensive experience and advanced platforms, we can provide a series of AI-augmented antibody discovery services for research, diagnostics, and therapeutics. Now we offer a unique way to find rare antibody clusters by augmenting our screening services with an AI-powered antibody drug discovery platform.
Advantages of AI-powered Antibody Discovery
Artificial intelligence (AI) technologies have also been widely used in antibody design based on big data and machine learning. In addition, the biophysical features of candidate antibodies, such as stability, solubility, chemical properties can be evaluated and optimized by different types of AI models to reduce the cost and improve the therapeutic efficiency.
AI can typically generate 10 times more antibody sequence clusters than a laboratory-based approach alone.
Antibody diversity expanded by AI leads to the discovery of new binding modalities and potentially new therapeutic modes-of-action.
